Evidence map›Paper›PMID 41883438›Full record

ArticleWorld journal of experimental medicine2026

Differences of immunohistochemical profiling of MOC-31, caveolin-1, connexin-43, Ki-67 in ameloblastic fibroma, ameloblastic fibrodentinoma, ameloblastic fibro-odontoma, and odontomas.

Natalia González Umpiérrez, Estefania Sicco, Felipe Silveira, Aurita Veronica Beovide, Ronell Bologna-Molina

Abstract read
In one paragraph

Article in World journal of experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Natalia González UmpiérrezDepartment of Diagnostic in Oral Pathology and Oral Medicine, Faculty of Dentistry, University of the Republic, Montevideo 14200, Uruguay.
Estefania SiccoDepartment of Diagnostic in Oral Pathology and Oral Medicine, Faculty of Dentistry, University of the Republic, Montevideo 14200, Uruguay.
Felipe SilveiraDepartment of Diagnostic in Oral Pathology and Oral Medicine, Faculty of Dentistry, University of the Republic, Montevideo 14200, Uruguay.
Aurita Veronica BeovideDepartment of Diagnostic in Oral Pathology and Oral Medicine, Faculty of Dentistry, University of the Republic, Montevideo 14200, Uruguay.
Ronell Bologna-MolinaDepartment of Diagnostic in Oral Pathology and Oral Medicine, Faculty of Dentistry, University of the Republic, Montevideo 14200, Uruguay. ronellbologna@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOdontogenic tumors are a heterogeneous group of lesions originating from tissues involved in odontogenesis. Mixed odontogenic tumors comprise a group of lesions characterized by the presence of ectodermal and mesenchymal odontogenic tissues with or without the formation of hard dental tissues.

aimTo determine and compare the expression of caveolin-1, MOC-31, connexin-43 (Cx-43), and Ki-67 in ameloblastic fibromas (AF), ameloblastic fibrodentinomas (AFD), ameloblastic fibro-odontomas (AFO), and odontomas (O).

methodsImmunohistochemical analysis for caveolin-1, MOC-31, Cx-43, and Ki-67 was performed on eight AF, one AFD, five AFO, and six O.

resultsVariable protein expression was identified in the epithelium and mesenchyme of most AF, AFD, and AFO with lower expression observed in O. Immunohistochemical analysis revealed significant differences in protein expression between AF and O (

conclusionThis immunohistochemical study suggested that the similarity in protein expression between AFD, AFO, and AF compared with O may be due to the biological proximity among these lesions at the protein expression level. Further studies with larger sample sizes and complementary techniques are required to validate these findings.

Indexed as

Caveolin-1Connexin-43Ki-67MOC-31Odontogenic tumors

Identifiers

PMID41883438
PMCPMC13010675

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.